The FDA gave emergency use authorization to the Pfizer vaccine for use in children aged 12-15. Pediatricians and pharmacies could start administering the shots as early as Thursday.
By expanding vaccine availability to young teenagers means about 13 million Americans are eligible for the vaccine, a move that experts say brings us closer to herd immunity.
As children have returned to school, they’ve become one of the most vulnerable groups in America.
Last week alone, there were more than 72,000 new pediatric cases identified in the U.S.